- Home
- SQFT vs SNOA Comparison
SQFT vs SNOA Comparison
Compare SQFT & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- SNOA
- Stock Information
- Founded
- SQFT 1999
- SNOA 1999
- Country
- SQFT United States
- SNOA United States
- Employees
- SQFT N/A
- SNOA N/A
- Industry
- SQFT Real Estate Investment Trusts
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- SQFT Real Estate
- SNOA Health Care
- Exchange
- SQFT Nasdaq
- SNOA Nasdaq
- Market Cap
- SQFT 6.2M
- SNOA 6.4M
- IPO Year
- SQFT 2020
- SNOA 2007
- Fundamental
- Price
- SQFT $5.15
- SNOA $3.61
- Analyst Decision
- SQFT
- SNOA
- Analyst Count
- SQFT 0
- SNOA 0
- Target Price
- SQFT N/A
- SNOA N/A
- AVG Volume (30 Days)
- SQFT 12.4K
- SNOA 74.2K
- Earning Date
- SQFT 08-13-2025
- SNOA 08-07-2025
- Dividend Yield
- SQFT N/A
- SNOA N/A
- EPS Growth
- SQFT N/A
- SNOA N/A
- EPS
- SQFT N/A
- SNOA N/A
- Revenue
- SQFT $18,260,398.00
- SNOA $14,288,000.00
- Revenue This Year
- SQFT $23.63
- SNOA $38.54
- Revenue Next Year
- SQFT N/A
- SNOA N/A
- P/E Ratio
- SQFT N/A
- SNOA N/A
- Revenue Growth
- SQFT N/A
- SNOA 12.20
- 52 Week Low
- SQFT $4.19
- SNOA $1.75
- 52 Week High
- SQFT $8.77
- SNOA $9.37
- Technical
- Relative Strength Index (RSI)
- SQFT 51.05
- SNOA 62.41
- Support Level
- SQFT $4.55
- SNOA $2.97
- Resistance Level
- SQFT $5.77
- SNOA $3.04
- Average True Range (ATR)
- SQFT 0.37
- SNOA 0.23
- MACD
- SQFT 0.09
- SNOA 0.09
- Stochastic Oscillator
- SQFT 56.96
- SNOA 59.71
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.